...
首页> 外文期刊>Acta biomaterialia >In situ generation of sodium alginate/hydroxyapatite nanocomposite beads as drug-controlled release matrices.
【24h】

In situ generation of sodium alginate/hydroxyapatite nanocomposite beads as drug-controlled release matrices.

机译:海藻酸钠/羟基磷灰石纳米复合材料珠的原位产生作为药物控制释放基质。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In order to find a new way to slow down the release of drugs and to solve the burst release problem of drugs from traditionally used hydrogel matrices, a series of novel pH-sensitive sodium alginate/hydroxyapatite (SA/HA) nanocomposite beads was prepared by the in situ generation of HA micro-particles in the beads during the sol-gel transition process of SA. The SA/HA nanocomposites were characterized by Fourier transform IR spectroscopy, X-ray fluorescence spectrometry, scanning electron microscopy and field emission SEM in order to reveal their composition and surface morphology as well as the role that the in situ generated HA micro-particles play. The factors influencing the swelling behavior, drug loading and controlled release behavior of the SA/HA nanocomposite beads were also investigated using diclofenac sodium (DS) as the model drug. The HA micro-particles act as inorganic crosslinkers in the nanocomposites, which could contract and restrict the movability of the SA polymer chains, and then change the surface morphology and decrease the swell ratio. Meanwhile, the entrapment efficiency of DS was improved, and the burst release of DS was overcome. The factors (including concentration of Ca(2+), reaction time and temperature) affecting the growth of HA micro-particles have a clear influence on the entrapment efficiency and release rate of DS. In this work, the nanocomposite beads prepared under optimum condition could prolong the release of DS for 8h more compared with the pristine SA hydrogel beads.
机译:为了找到一种减慢药物释放速度的新方法,并解决传统使用的水凝胶基质中药物的突释问题,本发明人制备了一系列新型的pH敏感的藻酸钠/羟磷灰石(SA / HA)纳米复合微珠。 SA的溶胶-凝胶转变过程中珠粒中HA微粒的原位生成。通过傅立叶变换红外光谱,X射线荧光光谱,扫描电子显微镜和场发射SEM对SA / HA纳米复合材料进行表征,以揭示其组成和表面形态以及原位生成的HA微粒发挥的作用。 。还使用双氯芬酸钠(DS)作为模型药物研究了SA / HA纳米复合材料微珠的溶胀行为,载药量和控释行为的影响因素。 HA微粒充当纳米复合物中的无机交联剂,其可以收缩并限制SA聚合物链的可移动性,然后改变表面形态并降低溶胀率。同时,提高了DS的包封效率,克服了DS的爆发释放。影响HA微粒生长的因素(包括Ca(2+)的浓度,反应时间和温度)对DS的包封效率和释放速率有明显影响。在这项工作中,与原始SA水凝胶珠相比,在最佳条件下制备的纳米复合珠可将DS的释放延长8小时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号